"Designing Growth Strategies is in our DNA"

Cachexia – Pipeline Review, 2019

Region : Global | Report ID: FBI101286

 

KEY MARKET INSIGHTS

Cachexia is a disorder that causes extreme weight loss, muscle wasting and fat loss. Cachexia is also referred to as wasting syndrome. Cachexia is commonly identified in the patients with the last stage of cancer, human immunodeficiency virus (HIV), chronic obstructive pulmonary disease (COPD), kidney disease and congestive heart failure (CHF). Cachexia is classified into pre-cachexia, cachexia, and refractory cachexia. Symptoms observed in patients with cachexia are reduced muscle strength, fatigue, anorexia, low fat-free mass index, high levels of inflammation, anemia, low levels of the protein and albumin.


There are no treatments available for the complete cure of the cachexia. However, several types of therapies and measures are taken to improve the symptoms. Currently available treatments for cachexia include providing appetite stimulant, medications to improve nausea and moods, drugs to decrease inflammation, diet, and exercise.


Research Institutes and pharmaceutical companies are focusing on studying and developing new methods for the treatment of cachexia. For instance; NGM120 is being studied by NGM Biopharmaceuticals, Inc., is currently in phase 1 of a clinical trial for the study to evaluate the safety, and tolerability of NGM120 in healthy adults suffering with cachexia. PINTA 745 is a drug which is being studied by Pinta Biotherapeutics, to evaluate its effect on end-stage renal disease and protein-energy wasting and is currently in phase 1 of clinical trial.


Currently, more than 50% of the pipeline candidates for cachexia are in phase 2 and phase 3 of clinical trials. Majority of the studies have been sponsored by research institutes, specialty centers & hospitals.


REPORT DESCRIPTION


The report on ‘Cachexia – Pipeline Review, 2019’ provides a comprehensive overview of the drugs that are in the R&D pipeline by indication or molecule for cachexia. The report provides a thorough analysis of the distribution of the pipeline products by clinical trial stage, indication, company, therapy area and details such as clinical trial stage, sponsor, description on every product in the pipeline. Products in the preclinical and clinical stage along with dormant & discontinued pipeline candidates are included in the report. The report also covers additional insights such as epidemiology overview and current market scenario for cachexia.


The report on ‘Cachexia – Pipeline Review, 2019’, which is built by following a robust research methodology involving primary interviews and desk research, provides a complete overview of the R&D activity and pipeline products to assist companies in developing growth strategies and identifying emerging players.


Report Scope



  • Thorough assessment of the pipeline products by areas such as development stage; route of administration; drug class; indication; sponsor; molecule type and drug target

  • Comprehensive profiles of the pipeline products with details such as company overview; product description; R&D status; development activities; mechanism of action; molecule type; development stage; indications; funding and route of administration

  • Overview of dormant and discontinued pipeline products

  • Key insights in relation to the epidemiology of conditions being treated by the pipeline products and overview of the addressable or current market for the pipeline products

  • Overview of the latest developments; news articles, press releases and relevant conferences


Report Methodology



  • All pipeline reports are built through the analysis of data primarily collected through credible desk research sources. Secondary research is supplemented by interviews conducted with key opinion leaders.

  • Desk research sources includes global and regional clinical trials databases; annual reports, websites, press releases & investor presentations of companies; white papers; news articles; reports published by industry associations; articles/reports published on databases such as NCBI, ResearchGate; internal databases


Reasons to Buy this Report



  • Develop effective growth strategies based on comprehensive overview of the R&D activity and pipeline products for cachexia

  • Identify emerging players or competition in the market based on pipeline products and develop strategies to counter the emergence of these players

  • Identify the focus of leading players in relation to R&D for cachexia

  • Identify potential companies from a partnership or acquisition point of view based on current synergy in R&D activities or strategies to diversify R&D focus to drive growth in business

  • Analyse the reasons behind dormant and discontinued products to make changes in the R&D focus if necessary


Cachexia Pipelin Review

    CHOOSE LICENSE TYPE

  • 2050
    4150
    6150

Healthcare Clients

Fresenius
Jubilant
uniliver
Ansell
Lek

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X